Literature DB >> 26951863

Long story short: p53 mediates innate immunity.

Jessica Miciak1, Fred Bunz2.   

Abstract

The story of p53 and how we came to understand it is punctuated by fundamental insights into the essence of cancer. In the decades since its discovery, p53 has been shown to be centrally involved in most, if not all, of the cellular processes that maintain tissue homeostasis. Extensive functional analyses of p53 and its tumor-associated mutants have illuminated many of the common defects shared by most cancer cells. As the central character in a tale that continues to unfold, p53 has become increasingly familiar and yet remains surprisingly inscrutable. New relationships periodically come to light, and surprising, novel activities continue to emerge, thereby revealing new dimensions and aspects of its function. What lies at the very core of this complex protagonist? What is its prime motivation? As every avid reader knows, the elements of character are profoundly shaped by adversity--originating from within and without. And so it is with p53. This review will briefly recap the coordinated responses of p53 to viral infection, and outline a hypothetical model that would explain how an abundance of seemingly unrelated phenotypic attributes may in the end reflect a singular function. All stories eventually draw to a conclusion. This epic tale may eventually leave us with the realization that p53, most simply described, is a protein that evolved to mediate immune surveillance.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenovirus; DNA damage; Interferon; P53

Mesh:

Substances:

Year:  2016        PMID: 26951863      PMCID: PMC4860023          DOI: 10.1016/j.bbcan.2016.03.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  88 in total

1.  Role for p53 in gene induction by double-stranded RNA.

Authors:  B T Hummer; X L Li; B A Hassel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  Mechanisms of E3 modulation of immune and inflammatory responses.

Authors:  S P Fessler; F Delgado-Lopez; M S Horwitz
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

3.  The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2.

Authors:  F Krätzer; O Rosorius; P Heger; N Hirschmann; T Dobner; J Hauber; R H Stauber
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

Review 4.  The oncogenic DNA viruses: a review of in vitro transformation studies.

Authors:  P H Black
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

Review 5.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

6.  Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.

Authors:  Travis H Stracker; Christian T Carson; Matthew D Weitzman
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

7.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.

Authors:  P R Yew; A J Berk
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

8.  The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells.

Authors:  M E Blair Zajdel; G E Blair
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

9.  High-efficiency targeted editing of large viral genomes by RNA-guided nucleases.

Authors:  Yanwei Bi; Le Sun; Dandan Gao; Chen Ding; Zhihua Li; Yadong Li; Wei Cun; Qihan Li
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

10.  The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.

Authors:  Jasdave S Chahal; Ji Qi; S J Flint
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

View more
  25 in total

1.  A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.

Authors:  Zhaoshou Yang; Yongheng Hou; Taofang Hao; Hee-Sool Rho; Jun Wan; Yizhao Luan; Xin Gao; Jianping Yao; Aihua Pan; Zhi Xie; Jiang Qian; Wanqin Liao; Heng Zhu; Xingwang Zhou
Journal:  Mol Cell Proteomics       Date:  2017-01-13       Impact factor: 5.911

Review 2.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

3.  Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear Accumulations.

Authors:  Martina Dezeljin; Martin Messerle; Ivana Kutle; Katarzyna M Szymańska-de Wijs; Boris Bogdanow; Berislav Cuvalo; Lars Steinbrück; Stipan Jonjić; Karen Wagner; Rainer Niedenthal; Matthias Selbach; Lüder Wiebusch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

Review 4.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

Review 5.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

6.  Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1.

Authors:  Jasmine Rae Frost; Megan Mendez; Andrea Michelle Soriano; Leandro Crisostomo; Oladunni Olanubi; Sandi Radko; Peter Pelka
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

7.  Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo.

Authors:  Juliana G Xande; Ana P Dias; Rodrigo E Tamura; Mario C Cruz; Bárbara Brito; Robledo A Ferreira; Bryan E Strauss; Eugenia Costanzi-Strauss
Journal:  Gene Ther       Date:  2019-08-22       Impact factor: 5.250

Review 8.  Opposing Roles of Type I Interferons in Cancer Immunity.

Authors:  Giselle M Boukhaled; Shane Harding; David G Brooks
Journal:  Annu Rev Pathol       Date:  2020-12-02       Impact factor: 23.472

9.  The complexity of p53-mediated metabolic regulation in tumor suppression.

Authors:  Yanqing Liu; Wei Gu
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 17.012

Review 10.  Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy.

Authors:  Yong Liu; Patrick L Leslie; Yanping Zhang
Journal:  Trends Cancer       Date:  2020-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.